Procter & Gamble Hygiene and Health Care (500459) Investor Update summary
Event summary combining transcript, slides, and related documents.
Investor Update summary
3 Feb, 2026Financial performance and growth
Achieved 7% sales growth to INR 4,192 crore and 19% operational profit growth, with structural margins improving by 400 basis points due to productivity and premiumization efforts.
Consistent high single-digit sales and profit growth over 10 years, with return on equity doubling and share price tripling.
Net sales and PAT have more than doubled over the past decade, with 7% and 8% CAGR respectively.
FemCare contributes 70% and healthcare 30% of revenue, with balanced growth across both segments.
Maintained share leadership despite macro and competitive challenges.
Strategic initiatives and innovation
Integrated Growth Strategy focuses on product superiority, productivity, constructive disruption, and an agile organization.
Innovations include Whisper Ultra XL for heavy flow, Vicks Cough Drops Double Power, Vicks VapoRub Steam Pods, and Vicks Roll-On.
Lean innovation and digitization initiatives, including AI-based quality control and supply chain optimization, are driving efficiency.
Achieved INR 113 crores in productivity savings for FY 23/24, integrating productivity into strategy to fuel investments.
Diverse portfolio includes leading brands in feminine care, health care, baby, grooming, and home care.
Market and category trends
FemCare market has grown 100x in 30 years, now at INR 3,400 crore, with double-digit growth expected over the next three years.
Urban penetration is about 60%, rural below 40%, with significant headroom for growth; unorganized and D2C players represent less than 10% of the market.
FMCG industry volume growth at 4%, with green shoots in rural demand due to good monsoons and softening inflation.
India’s macroeconomic indicators remain strong, with GDP growth returning to record highs and tax collections and forex reserves at all-time highs.
Positive consumption trends supported by lower inflation, strong monsoons, and rural consumption recovery.
Latest events from Procter & Gamble Hygiene and Health Care
- Strong quarterly growth and a special dividend highlight robust performance.500459
Q3 25/2630 Jan 2026 - 9-month profit after tax reached ₹637 crore, with EPS at ₹196.11 and ₹175 per share dividend declared.500459
Q4 24/2519 Jan 2026 - Q2 FY25 saw strong revenue and profit growth, with EPS up to ₹65.28.500459
Q2 24/2515 Dec 2025 - Quarterly net profit reached ₹21,190 lakhs with EPS of ₹64.65 and strong cash reserves.500459
Q2 25/2615 Dec 2025 - Strong revenue and profit growth with a ₹110 interim dividend and a shift to a March 31 year-end.500459
Q3 24/2515 Dec 2025 - Net profit rose to ₹19,206 lakhs, with EPS at ₹59.17 and strong year-over-year growth.500459
Q1 25/2615 Dec 2025